KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zimmer Biomet Holdings (ZBH) Payables (2016 - 2025)

Zimmer Biomet Holdings (ZBH) has 17 years of Payables data on record, last reported at $303.0 million in Q4 2025.

  • For Q4 2025, Payables rose 55.7% year-over-year to $303.0 million; the TTM value through Dec 2025 reached $303.0 million, up 55.7%, while the annual FY2025 figure was $303.0 million, 55.7% up from the prior year.
  • Payables reached $303.0 million in Q4 2025 per ZBH's latest filing, down from $315.3 million in the prior quarter.
  • Across five years, Payables topped out at $437.1 million in Q4 2022 and bottomed at $194.6 million in Q4 2024.
  • Average Payables over 5 years is $335.2 million, with a median of $328.7 million recorded in 2021.
  • Peak YoY movement for Payables: tumbled 52.61% in 2024, then soared 55.7% in 2025.
  • A 5-year view of Payables shows it stood at $306.5 million in 2021, then surged by 42.61% to $437.1 million in 2022, then dropped by 6.06% to $410.6 million in 2023, then crashed by 52.61% to $194.6 million in 2024, then soared by 55.7% to $303.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Payables were $303.0 million in Q4 2025, $315.3 million in Q3 2025, and $348.7 million in Q2 2025.